SAMBATARO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 1.402
AS - Asia 524
EU - Europa 271
SA - Sud America 188
AF - Africa 11
OC - Oceania 1
Totale 2.397
Nazione #
US - Stati Uniti d'America 1.373
SG - Singapore 159
BR - Brasile 145
HK - Hong Kong 141
VN - Vietnam 98
IT - Italia 85
CN - Cina 60
DE - Germania 55
FR - Francia 40
IE - Irlanda 24
AR - Argentina 23
CA - Canada 20
AT - Austria 17
BD - Bangladesh 15
GB - Regno Unito 13
ID - Indonesia 12
FI - Finlandia 10
EC - Ecuador 9
NL - Olanda 8
TR - Turchia 8
MX - Messico 7
IN - India 6
ZA - Sudafrica 6
CL - Cile 5
IQ - Iraq 5
RU - Federazione Russa 5
AZ - Azerbaigian 4
JP - Giappone 3
MA - Marocco 3
PL - Polonia 3
UZ - Uzbekistan 3
ES - Italia 2
IL - Israele 2
PY - Paraguay 2
SE - Svezia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
SA - Arabia Saudita 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.397
Città #
Dallas 1.205
Hong Kong 140
Singapore 80
Ho Chi Minh City 49
Dublin 24
The Dalles 24
Beijing 19
Ashburn 18
Santa Clara 15
Naples 14
São Paulo 14
Milan 12
Hanoi 11
Frankfurt am Main 9
Catania 8
Helsinki 8
Montreal 8
Boardman 7
Istanbul 7
Munich 7
Rio de Janeiro 7
Düsseldorf 6
Los Angeles 6
New York 6
Biên Hòa 5
Brasília 5
Misilmeri 5
Nuremberg 5
Vienna 5
Assago 4
Baku 4
Boston 4
Brooklyn 4
Curitiba 4
Haiphong 4
Palermo 4
Porto Alegre 4
Quito 4
Triggiano 4
Amsterdam 3
Baghdad 3
Campinas 3
Casoria 3
Chennai 3
Dhaka 3
Durban 3
Guayaquil 3
Manchester 3
Mexico City 3
Ribeirão Preto 3
Rome 3
San Francisco 3
Seattle 3
Tashkent 3
Varallo Pombia 3
Warsaw 3
Abbotsford 2
Avellino 2
Bandung 2
Belo Horizonte 2
Buenos Aires 2
Chicago 2
Da Nang 2
Duque de Caxias 2
Fortaleza 2
General Roca 2
Guarulhos 2
Hortolândia 2
Hải Dương 2
Ijuí 2
Independencia 2
Isidro Casanova 2
Johannesburg 2
Joinville 2
Kyiv 2
Lauterbourg 2
London 2
Machala 2
Manaus 2
Miami 2
Moscow 2
Osaka 2
Phủ Lý 2
Piritiba 2
Portsmouth 2
Quảng Ngãi 2
Resistencia 2
Salvador 2
San Jose 2
Santiago 2
Santo André 2
Secaucus 2
Stockholm 2
São José 2
Thái Nguyên 2
Três Lagoas 2
Turku 2
Vancouver 2
Viamão 2
Agrigento 1
Totale 1.907
Nome #
Opsoclonus-myoclonus Syndrome in a Female Breast Cancer Patient: A Case Report and Literature Review 269
Neurocrine tumors of the lung [I TUMORI NEUROENDOCRINI DEL POLMONE] 250
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 215
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: A phase II study 182
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 67
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 67
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy 63
Brain Metastasis in Endometrial Cancer: A Systematic Review 59
Nonpegylated liposome-encapsulated doxorubicin (NPLED) and cyclophosphamide in the treatment of platinum-resistant ovarian cancer: Final results of a phase II study 58
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 54
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 48
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 44
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 44
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 43
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 43
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 43
IL-6-174 G>C and MMP-9-1562 C>T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients 41
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 41
Chemotherapy extravasation: diagnosis, prevention and management 39
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 39
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 39
[Second-line chemotherapy and new drugs for ovarian carcinoma] 38
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 38
LONG-TERM CANCER SURVIVORS: CONCERNS AND UPDATES 37
Prognostic Factors for Adrenocortical Carcinoma Outcomes 37
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 36
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial 35
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer 35
A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features 33
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study 33
Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante Livelli sierici del recettore solubile dell’interleuchina 2 in pazienti con carcinoma del polmone in stadio III o IV in trattamento antiblastico o radiante 31
Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network 31
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial 30
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 29
Effectiveness of low molecular weight heparin (LMWH) in cancer-related disseminated intravascular coagulation (DIC). A case report 29
Bronchial carcinoid associated with Cushing's syndrome 28
Bronchial carcinoid associated to Cushing syndrome|IL CARCINOIDE BRONCHIALE ASSOCIATO A SINDROME DI CUSHING 27
The immune system response during development and progression of carcinogen-induced rat mammary tumors: prevention of tumor growth and restoration of immune system responsiveness by thymopentin 22
The pathology of medullary carcinoma of the thyroid: Review of the literature and personal experience on 62 cases 22
Exploratory Analysis of Dunning–Kruger Effect Among Oncologists Managing Prostatic Adenocarcinoma Candidates for Radionuclide Therapy 15
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 14
Pegylated liposomial doxorubicin with escalating dose vinorelbina in metastatic breast carcinoma: a dose finding study. 11
Escalating Doses of gemcitabine in combination with cisplatin in advanced urothelial carcinoma: a dose finding study. 10
Il deficit cognitivo nei pazienti oncologici in trattamento antiblastico. 10
Melanoma Sliding Doors 2022 Management and targeted treatment for melanoma BRAF+ patients 8
Study on the perception of memory and concentration deficit of patients undergoing antiblastic therapy. 8
Follow up of colorectal cancer 8
Oxaliplatin (L-OHP), folinic and fluorouracil (5FU) for advanced breast cancer (BC) patients (pts) refractary to anthracyclines (ant) and taxanes (tax). 8
Doppia modulazione del 5 FU con Leucovorin ed Interferon * nel carcinoma colorettale in stadio avanzato. Risultati di uno studio clinico. 7
Trombosi e Cancro 6
A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival 6
Melanoma Setting Next Horizon 2023. Mnagement and targeted treatment for melanoma BRAF+ Patients. 6
Retrospective study about treatment protocol of an advanced colorectal carcinoma by 5fluouracil double modulation by leucovorin and interferon. 5
Effetto dell’interleuchina 2 sulla mucosite indotta da trattamento citostatico con 5 fluorouracile ad alte dosi in infusione continua e acido folinico in pazienti con adenocarcinoma del colon retto in stadio avanzato. 5
Importanza di una adeguata terapia nutrizionale di supporto nel paziente neoplastico in fase avanzata: l’esperienza di un day hospital oncologico. 5
The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience 5
Assessing awareness and knowledge of Human Papilloma virus infection in high school studente 5
Tossicità dell’associazione RT-CT nel carcinoma del retto: valutazione della fattibilità in rapporto al regime citostatico adottato 5
Escalating Doses of Paclitaxel in combination with Epirubicin and Cisplatin in Advanced Ovarian Epithelial Carcinoma: A Dose Finding Study. 5
Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study. 5
Terapia adiuvante e qualità di vita: tossicità del trattamento con folati e 5-FU a scopo precauzionale e sue implicazioni cliniche 5
PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG 4
Adjuvant treatment of colo-rectal cancer with combined chemotherapy and radiation therapy 4
Nutritional Status, Inflammatory Parameters and Cancer 4
Utilità di un follow up accurato nel trattamento delle metastasi polmonari ed epatiche da carcinoma colo-rettale: descrizione di due casi clinici. 4
Il trattamento del carcinoma gastrico localmente avanzato e metastatico in regime di day hospital: possibilità di applicazione dell’infusione continua (ECF) 4
Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC) 4
Il sistema immunitario durante la progressione tumorale: approccio sperimentale e clinico 4
Chemotherapy for transitional cell carcinoma (TCC) patients (pts) unsuitable to cisplatinum: a phase II study of gemcitabine (G) and vinorelbine (V) combination. 4
Neoadjuvant chemotherapy followed by surgery in patients with squamous cell cervical carcinoma 4
Tumor markers in the diagnosis, prognosis, and follow-up of colorectal cancer: CEA, CA 19-9 and TPA 4
Gemcitabine (G) as a six-hour infusion in patients (pts) with metastatic, largely treated, solid tumours. 4
Descrizione e valutazione di alcuni casi di metastasi epatiche da carcinomi del grosso intestino trattate con terapia citostatica e successiva resezione 4
Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study. 4
MITO-11 - A randomized multicenter phase II trial testing the addition of pazopanib to weekly paclitaxel in platinum resistant or refractory advanced ovarian cancer (AOC) 3
Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire. 3
Valutazione di CEA, TPA E CA 15.3 nel follow-up del carcinoma della mammella e nel monitoraggio della risposta alla terapia nella fase avanzata. 3
5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial 3
Neuroimmunomodulation in Neoplasia: Role of Cytokines and Thimic Hormones 3
Metronomic shedule of Capecitabine in poor performance status Patients (PTS) with pretreated solid tumors 3
Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture. 3
Phase II study of irinotecan and fluorouracil/leucovorin (FOLFIRI) in patients with primary advanced gastric cancer. Preliminary results 2
Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16 2
ATHENA (GOG-3020/ENGOT-ov45): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study of the Poly (ADP-Ribose) Polymerase (PARP) Inhibitor Rucaparib + the PD-1 Inhibitor Nivolumab Following Frontline Platinum-Based Chemotherapy in Ovarian Cancer 2
Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department 2
Beyond BRCA: preliminary results of a study for the implementation of hereditary cancer diagnoses. 2
Tromboembolismo in oncologia medica 2
THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES 2
Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice 2
The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems The Astrocyte as Target and Source of Mediators of Immune and Neuroendocrine Systems 2
Toxicity From Monoimmunotherapy In Patients Aged =80 Years: Our Experience 2
Determinazione della Triiodiotironina con tecniche immunochimiche non radioisotopiche Determination of Triiodiothyronine by non radioisotopic techniques 1
Totale 2.575
Categoria #
all - tutte 8.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20245 0 0 0 0 0 0 0 0 0 0 0 5
2024/2025610 12 5 9 2 18 96 68 44 69 121 84 82
2025/20261.960 103 282 1.122 256 197 0 0 0 0 0 0 0
Totale 2.575